Antitrust Investigation Targets Novo Nordisk and Sanofi Over Insulin Pricing in South Africa

In a significant development in the pharmaceutical sector, Danish pharmaceutical giant Novo Nordisk along with French company Sanofi is facing scrutiny from South African authorities concerning possible antitrust violations related to insulin pricing. The investigation aims to explore whether these companies engaged in unfair practices that may have contributed to the increased costs of insulin, a critical medication for diabetics, thus affecting public health.

Continue reading

India Denies Apple’s Request to Halt Antitrust Investigation

In a significant blow to Apple Inc., the Indian government has officially rejected the tech giant's request to pause a forthcoming antitrust report. The investigation, which was initiated by India’s Competition Commission (CCI), stems from allegations that Apple has engaged in anti-competitive practices within its App Store.

Continue reading